Abnormal Type I Collagen Post-translational Modification and Crosslinking in a Cyclophilin B KO Mouse Model of Recessive Osteogenesis Imperfecta

PLoS Genetics

Volumn 10, Issue 6, 2014, Pages

  Cabral, Wayne A ^a   Perdivara, Irina ^b   Weis, MaryAnn ^c   Terajima, Masahiko ^d   Blissett, Angela R ^a   Chang, Weizhong ^a,f   Perosky, Joseph E ^e   Makareeva, Elena N ^a   Mertz, Edward L ^a   Leikin, Sergey ^a   Tomer, Kenneth B ^b   Kozloff, Kenneth M ^e   Eyre, David R ^c   Yamauchi, Mitsuo ^d   Marini, Joan C ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; CYCLOPHILIN B; CYCLOSPORIN A; PROCOLLAGEN LYSINE 2 OXOGLUTARATE 5 DIOXYGENASE; COLLAGEN; CYCLOPHILIN; GLYCOSYLATED COLLAGEN; MEMBRANE PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE MASS; BONE STRENGTH; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; GENE; GENE FUNCTION; GENE MUTATION; GENETIC ASSOCIATION; HYDROXYLATION; MALE; MOUSE; NONHUMAN; OSTEOGENESIS IMPERFECTA; PPIB GENE; PROTEIN CROSS LINKING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION; ANIMAL; CHEMISTRY; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; MUTATION; PATHOLOGY; RECESSIVE GENE;

ANIMALS; COLLAGEN; COLLAGEN TYPE I; CYCLOPHILINS; EXTRACELLULAR MATRIX; GENES, RECESSIVE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MUTATION; OSTEOGENESIS IMPERFECTA; PROTEIN FOLDING; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84903481605     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004465     Document Type: Article

References (75)

1. Myllyharju J, Kivirikko KI, (2004) Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet 20: 33-43.
2. Knott L, Bailey AJ, (1998) Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance. Bone 22: 181-187.
3. Eyre DR, Wu J (2005) Collagen Cross-Links. In: Brinckmann J, Notbohm H, Muller PK, Eds. Collagen: Primer in Structure, Processing and Assembly. Berlin: Springer Berlin Heidelberg. pp. 207-229.
4. Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, et al. (2007) Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 28: 209-221.
5. Forlino A, Cabral WA, Barnes AM, Marini JC, (2011) New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol 7: 540-557.
6. Marini JC, Cabral WA, Barnes AM, Chang W, (2007) Components of the collagen prolyl 3-hydroxylation complex are crucial for normal bone development. Cell Cycle 6: 1675-1681.
7. Vranka JA, Sakai LY, Bachinger HP, (2004) Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes. J Biol Chem 279: 23615-23621.
8. Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, et al. (2006) CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127: 291-304.
9. Ishikawa Y, Wirz J, Vranka JA, Nagata K, Bachinger HP, (2009) Biochemical characterization of the prolyl 3-hydroxylase 1/CRTAP/cyclophilin B complex. J Biol Chem 284: 17641-17647.
10. Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, et al. (2007) Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Nat Genet 39: 359-365.
11. van Dijk FS, Nesbitt IM, Zwikstra EH, Nikkels PG, Piersma SR, et al. (2009) PPIB mutations cause severe osteogenesis imperfecta. Am J Hum Genet 85: 521-527.
12. Chang W, Barnes AM, Cabral WA, Bodurtha JN, Marini JC, (2009) Prolyl 3-hydroxylase 1 and CRTAP are mutually stabilizing in the endoplasmic reticulum collagen prolyl 3-hydroxylation complex. Hum Mol Genet 19: 223-234.
13. Galat A, (2003) Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity-targets-functions. Curr Top Med Chem 3: 1315-1347.
14. Gothel SF, Marahiel MA, (1999) Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. Cell Mol Life Sci 55: 423-436.
15. Meunier L, Usherwood YK, Chung KT, Hendershot LM, (2002) A subset of chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind nascent proteins. Mol Biol Cell 13: 4456-4469.
16. Jansen G, Maattanen P, Denisov AY, Scarffe L, Schade B, et al. (2012) An interaction map of endoplasmic reticulum chaperones and foldases. Mol Cell Proteomics 11: 710-723.
17. Steinmann B, Bruckner P, Superti-Furga A, (1991) Cyclosporin A slows collagen triple-helix formation in vivo: indirect evidence for a physiologic role of peptidyl-prolyl cis-trans-isomerase. J Biol Chem 266: 1299-1303.
18. Bachinger HP, Bruckner P, Timpl R, Prockop DJ, Engel J, (1980) Folding mechanism of the triple helix in type-III collagen and type-III pN-collagen. Role of disulfide bridges and peptide bond isomerization. Eur J Biochem 106: 619-632.
19. Barnes AM, Carter EM, Cabral WA, Weis M, Chang W, et al. (2010) Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding. N Engl J Med 362: 521-528.
20. Pyott SM, Schwarze U, Christiansen HE, Pepin MG, Leistritz DF, et al. (2011) Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes. Hum Mol Genet 20: 1595-1609.
21. Ishikawa Y, Vranka JA, Boudko SP, Pokidysheva E, Mizuno K, et al. (2012) Mutation in cyclophilin B that causes hyperelastosis cutis in American Quarter Horse does not affect peptidylprolyl cis-trans isomerase activity but shows altered cyclophilin B-protein interactions and affects collagen folding. J Biol Chem 287: 22253-22265.
22. Vranka JA, Pokidysheva E, Hayashi L, Zientek K, Mizuno K, et al. (2010) Prolyl 3-hydroxylase 1 null mice display abnormalities in fibrillar collagen-rich tissues such as tendons, skin, and bones. J Biol Chem 285: 17253-17262.
23. Barnes AM, Chang W, Morello R, Cabral WA, Weis M, et al. (2006) Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J Med 355: 2757-2764.
24. Sricholpech M, Perdivara I, Nagaoka H, Yokoyama M, Tomer KB, et al. (2011) Lysyl hydroxylase 3 glucosylates galactosylhydroxylysine residues in type I collagen in osteoblast culture. J Biol Chem 286: 8846-8856.
25. Sricholpech M, Perdivara I, Yokoyama M, Nagaoka H, Terajima M, et al. (2012) Lysyl hydroxylase 3-mediated glucosylation in type I collagen: molecular loci and biological significance. J Biol Chem 287: 22998-23009.
26. Schegg B, Hulsmeier AJ, Rutschmann C, Maag C, Hennet T, (2009) Core glycosylation of collagen is initiated by two beta(1-O)galactosyltransferases. Mol Cell Biol 29: 943-952.
27. Heikkinen J, Risteli M, Wang C, Latvala J, Rossi M, et al. (2000) Lysyl hydroxylase 3 is a multifunctional protein possessing collagen glucosyltransferase activity. J Biol Chem 275: 36158-36163.
28. Salo AM, Cox H, Farndon P, Moss C, Grindulis H, et al. (2008) A connective tissue disorder caused by mutations of the lysyl hydroxylase 3 gene. Am J Hum Genet 83: 495-503.
29. Myllyla R, Wang C, Heikkinen J, Juffer A, Lampela O, et al. (2007) Expanding the lysyl hydroxylase toolbox: new insights into the localization and activities of lysyl hydroxylase 3 (LH3). J Cell Physiol 212: 323-329.
30. Choi JW, Sutor SL, Lindquist L, Evans GL, Madden BJ, et al. (2009) Severe osteogenesis imperfecta in cyclophilin B-deficient mice. PLoS Genet 5: e1000750.
31. Baldridge D, Lennington J, Weis M, Homan EP, Jiang MM, et al. (2010) Generalized connective tissue disease in Crtap-/- mouse. PLoS One 5: e10560.
32. Pokidysheva E, Zientek KD, Ishikawa Y, Mizuno K, Vranka JA, et al. (2013) Posttranslational Modifications in Type I Collagen from Different Tissues extracted from wild type and Prolyl 3-hydroxylase 1 Null Mice. J Biol Chem 288: 24742-24752.
33. Raghunath M, Bruckner P, Steinmann B, (1994) Delayed triple helix formation of mutant collagen from patients with osteogenesis imperfecta. J Mol Biol 236: 940-949.
34. Bachinger HP, Morris NP, Davis JM, (1993) Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the triple helix of type I collagen. Am J Med Genet 45: 152-162.
35. Zeng B, MacDonald JR, Bann JG, Beck K, Gambee JE, et al. (1998) Chicken FK506-binding protein, FKBP65, a member of the FKBP family of peptidylprolyl cis-trans isomerases, is only partially inhibited by FK506. Biochem J 330 (Pt 1):: 109-114.
36. Barnes AM, Cabral WA, Weis M, Makareeva E, Mertz EL, et al. (2012) Absence of FKBP10 in recessive type XI osteogenesis imperfecta leads to diminished collagen cross-linking and reduced collagen deposition in extracellular matrix. Hum Mutat 33: 1589-1598.
37. Schwarze U, Cundy T, Pyott SM, Christiansen HE, Hegde MR, et al. (2013) Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen. Hum Mol Genet 22: 1-17.
38. Barnes AM, Duncan G, Weis M, Paton W, Cabral WA, et al. (2013) Kuskokwim Syndrome, a Recessive Congenital Contracture Disorder, Extends the Phenotype of FKBP10 Mutations. Hum Mutat 34: 1279-1288.
39. Baumann M, Giunta C, Krabichler B, Ruschendorf F, Zoppi N, et al. (2012) Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss. Am J Hum Genet 90: 201-216.
40. Eyre D, Shao P, Weis MA, Steinmann B, (2002) The kyphoscoliotic type of Ehlers-Danlos syndrome (type VI): differential effects on the hydroxylation of lysine in collagens I and II revealed by analysis of cross-linked telopeptides from urine. Mol Genet Metab 76: 211-216.
41. Uzawa K, Grzesik WJ, Nishiura T, Kuznetsov SA, Robey PG, et al. (1999) Differential expression of human lysyl hydroxylase genes, lysine hydroxylation, and cross-linking of type I collagen during osteoblastic differentiation in vitro. J Bone Miner Res 14: 1272-1280.
42. Uzawa K, Yeowell HN, Yamamoto K, Mochida Y, Tanzawa H, et al. (2003) Lysine hydroxylation of collagen in a fibroblast cell culture system. Biochem Biophys Res Commun 305: 484-487.
43. van der Slot AJ, Zuurmond AM, Bardoel AF, Wijmenga C, Pruijs HE, et al. (2003) Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J Biol Chem 278: 40967-40972.
44. Eyre DR, Glimcher MJ, (1972) Reducible crosslinks in hydroxylysine-deficient collagens of a heritable disorder of connective tissue. Proc Natl Acad Sci U S A 69: 2594-2598.
45. Pasquali M, Still MJ, Vales T, Rosen RI, Evinger JD, et al. (1997) Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI. Proc Assoc Am Physicians 109: 33-41.
46. Pinnell SR, Krane SM, Kenzora JE, Glimcher MJ, (1972) A heritable disorder of connective tissue. Hydroxylysine-deficient collagen disease. N Engl J Med 286: 1013-1020.
47. Passoja K, Rautavuoma K, Ala-Kokko L, Kosonen T, Kivirikko KI, (1998) Cloning and characterization of a third human lysyl hydroxylase isoform. Proc Natl Acad Sci U S A 95: 10482-10486.
48. Wang C, Luosujarvi H, Heikkinen J, Risteli M, Uitto L, et al. (2002) The third activity for lysyl hydroxylase 3: galactosylation of hydroxylysyl residues in collagens in vitro. Matrix Biol 21: 559-566.
49. Risteli M, Niemitalo O, Lankinen H, Juffer AH, Myllyla R, (2004) Characterization of collagenous peptides bound to lysyl hydroxylase isoforms. J Biol Chem 279: 37535-37543.
50. Sipila L, Ruotsalainen H, Sormunen R, Baker NL, Lamande SR, et al. (2007) Secretion and assembly of type IV and VI collagens depend on glycosylation of hydroxylysines. J Biol Chem 282: 33381-33388.
51. Vetter U, Weis MA, Morike M, Eanes ED, Eyre DR, (1993) Collagen crosslinks and mineral crystallinity in bone of patients with osteogenesis imperfecta. J Bone Miner Res 8: 133-137.
52. Bank RA, Tekoppele JM, Janus GJ, Wassen MH, Pruijs HE, et al. (2000) Pyridinium cross-links in bone of patients with osteogenesis imperfecta: evidence of a normal intrafibrillar collagen packing. J Bone Miner Res 15: 1330-1336.
53. Fujii K, Tanzer ML, (1977) Osteogenesis imperfecta: biochemical studies of bone collagen. Clin Orthop Relat Res pp. 271-277.
54. Eyre DR, Weis MA, (2013) Bone Collagen: New Clues to Its Mineralization Mechanism from Recessive Osteogenesis Imperfecta. Calcif Tissue Int 93: 338-347.
55. Hudson DM, Kim LS, Weis M, Cohn DH, Eyre DR, (2012) Peptidyl 3-hydroxyproline binding properties of type I collagen suggest a function in fibril supramolecular assembly. Biochemistry 51: 2417-2424.
56. Takaluoma K, Hyry M, Lantto J, Sormunen R, Bank RA, et al. (2007) Tissue-specific changes in the hydroxylysine content and cross-links of collagens and alterations in fibril morphology in lysyl hydroxylase 1 knock-out mice. J Biol Chem 282: 6588-6596.
57. Steinmann B, Eyre DR, Shao P, (1995) Urinary pyridinoline cross-links in Ehlers-Danlos syndrome type VI. Am J Hum Genet 57: 1505-1508.
58. Yamauchi M, Noyes C, Kuboki Y, Mechanic GL, (1982) Collagen structural microheterogeneity and a possible role for glycosylated hydroxylysine in type I collagen. Proc Natl Acad Sci U S A 79: 7684-7688.
59. Eyre DR, Glimcher MJ, (1973) Analysis of a crosslinked peptide from calf bone collagen: evidence that hydroxylysyl glycoside participates in the crosslink. Biochem Biophys Res Commun 52: 663-671.
60. Amblard D, Lafage-Proust MH, Chamson A, Rattner A, Collet P, et al. (2003) Lower bone cellular activities in male and female mature C3H/HeJ mice are associated with higher bone mass and different pyridinium crosslink profiles compared to C57BL/6J mice. J Bone Miner Metab 21: 377-387.
61. Banse X, Devogelaer JP, Lafosse A, Sims TJ, Grynpas M, et al. (2002) Cross-link profile of bone collagen correlates with structural organization of trabeculae. Bone 31: 70-76.
62. Banse X, Sims TJ, Bailey AJ, (2002) Mechanical properties of adult vertebral cancellous bone: correlation with collagen intermolecular cross-links. J Bone Miner Res 17: 1621-1628.
63. Stryke D, Kawamoto M, Huang CC, Johns SJ, King LA, et al. (2003) BayGenomics: a resource of insertional mutations in mouse embryonic stem cells. Nucleic Acids Res 31: 278-281.
64. McLeod MJ, (1980) Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology 22: 299-301.
65. Sinder BP, Eddy MM, Ominsky MS, Caird MS, Marini JC, et al. (2013) Sclerostin antibody improves skeletal parameters in a Brtl/+ mouse model of osteogenesis imperfecta. J Bone Miner Res 28: 73-80.
66. Bakker AD, Klein-Nulend J, (2012) Osteoblast isolation from murine calvaria and long bones. Methods Mol Biol 816: 19-29.
67. Bonadio J, Holbrook KA, Gelinas RE, Jacob J, Byers PH, (1985) Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta. J Biol Chem 260: 1734-1742.
68. Makareeva E, Mertz EL, Kuznetsova NV, Sutter MB, DeRidder AM, et al. (2008) Structural heterogeneity of type I collagen triple helix and its role in osteogenesis imperfecta. J Biol Chem 283: 4787-4798.
69. Yamauchi M, Katz EP, (1993) The post-translational chemistry and molecular packing of mineralizing tendon collagens. Connect Tissue Res 29: 81-98.
70. Yamauchi M, Shiiba M, (2008) Lysine hydroxylation and cross-linking of collagen. Methods Mol Biol 446: 95-108.
71. Eyre D, (1987) Collagen cross-linking amino acids. Methods Enzymol 144: 115-139.
72. Forlino A, D'Amato E, Valli M, Camera G, Hopkins E, et al. (1997) Phenotypic comparison of an osteogenesis imperfecta type IV proband with a de novo alpha2(I) Gly922 → Ser substitution in type I collagen and an unrelated patient with an identical mutation. Biochem Mol Med 62: 26-35.
73. Cabral WA, Mertts MV, Makareeva E, Colige A, Tekin M, et al. (2003) Type I collagen triplet duplication mutation in lethal osteogenesis imperfecta shifts register of alpha chains throughout the helix and disrupts incorporation of mutant helices into fibrils and extracellular matrix. J Biol Chem 278: 10006-10012.
74. Bateman JF, Golub SB, (1994) Deposition and selective degradation of structurally-abnormal type I collagen in a collagen matrix produced by osteogenesis imperfecta fibroblasts in vitro. Matrix Biol 14: 251-262.
75. Cabral WA, Makareeva E, Colige A, Letocha AD, Ty JM, et al. (2005) Mutations near amino end of alpha1(I) collagen cause combined osteogenesis imperfecta/Ehlers-Danlos syndrome by interference with N-propeptide processing. J Biol Chem 280: 19259-19269.